Vanda Pharmaceuticals Inc. (VNDA)

Vanda Pharmaceuticals Stock Forecast

Stock Price Forecast

The 5 analysts that cover Vanda Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $14.9, which forecasts a 109.27% increase in the stock price over the next year. The lowest target is $7.50 and the highest is $24.

Price Target: $14.9 (+109.27%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.50	$14.9	$14	$24
Change	+5.34%	+109.27%	+96.63%	+237.08%

Analyst Ratings

The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	2	2	2	2	3
Buy	1	1	1	1	1	1
Hold	0	0	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	4	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Les Sulewski Truist Securities	Truist Securities	Strong Buy Initiates $18	Strong Buy	Initiates	$18	+152.81%	Mar 5, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $22 → $24	Strong Buy	Maintains	$22 → $24	+237.08%	Feb 23, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $20 → $22	Strong Buy	Maintains	$20 → $22	+208.99%	Jan 5, 2026
Madison El-Saadi B. Riley Securities	B. Riley Securities	Strong Buy Maintains $11 → $14	Strong Buy	Maintains	$11 → $14	+96.63%	Dec 31, 2025
Chris Howerton Jefferies	Jefferies	Hold Maintains $5 → $7.5	Hold	Maintains	$5 → $7.5	+5.34%	Dec 31, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

262.25M

Increased by 21.35%

from 216.11M

Revenue Next Year

360.34M

Increased by 37.40%

from 262.25M

EPS This Year

-2.51

from -3.74

EPS Next Year

-0.77

from -2.51

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	268.68M	254.38M	192.64M	198.77M	216.11M	262.25M	360.34M
Revenue Growth	8.27%	-5.32%	-24.27%	3.18%	8.72%	21.35%	37.40%
EPS	0.58	0.11	0.04	-0.33	-3.74	-2.51	-0.77
EPS Growth	38.10%	-81.03%	-63.64%	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	281.2M	422.7M
Avg	262.3M	360.3M
Low	245.0M	319.5M

Revenue Growth

Revenue Growth	2026	2027	2028
High	30.1%	61.2%
Avg	21.4%	37.4%
Low	13.4%	21.8%

EPS Forecast

EPS	2026	2027	2028
High	-2.25	-0.45
Avg	-2.51	-0.77
Low	-2.73	-1.21

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.